Tempus, AstraZeneca and Pathos AI ink $200M deal for cancer foundation model – FirstWord Pharma

Tempus, AstraZeneca and Pathos AI ink 0M deal for cancer foundation model – FirstWord Pharma

Tempus, AstraZeneca and Pathos AI ink $200M deal for cancer foundation model  FirstWord Pharma

Article Source
https://firstwordpharma.com/story/5951809